JAK2 and myelofibrosis: The pathogenesis of primary myelofibrosis is not determined solely by alterations in JAK2, CALR, and MPL and likely involves a much broader landscape of somatic mutations, which themselves affect both clinical features of disease and overall survival in various capacities.